Drug Type Protein drug conjugate |
Synonyms |
Target |
Action inhibitors |
Mechanism Phosphatidylserine inhibitors(Phosphatidylserine inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | Sweden | 24 May 2024 |